Starkus JG - Search Results

1

The amiodarone derivative KB130015 activates hERG1 potassium channels via a novel mechanism.

Gessner G, Macianskiene R, Starkus JG, Schönherr R, Heinemann SH. Gessner G, et al. Among authors: starkus jg. Eur J Pharmacol. 2010 Apr 25;632(1-3):52-9. doi: 10.1016/j.ejphar.2010.01.010. Epub 2010 Jan 25. Eur J Pharmacol. 2010. PMID: 20097192 Free PMC article.

2

Mechanisms of the inhibition of Shaker potassium channels by protons.

Starkus JG, Varga Z, Schönherr R, Heinemann SH. Starkus JG, et al. Pflugers Arch. 2003 Oct;447(1):44-54. doi: 10.1007/s00424-003-1121-0. Epub 2003 Aug 12. Pflugers Arch. 2003. PMID: 12920598

3

Ion conduction through C-type inactivated Shaker channels.

Starkus JG, Kuschel L, Rayner MD, Heinemann SH. Starkus JG, et al. J Gen Physiol. 1997 Nov;110(5):539-50. doi: 10.1085/jgp.110.5.539. J Gen Physiol. 1997. PMID: 9348326 Free PMC article.

4

Macroscopic Na+ currents in the "Nonconducting" Shaker potassium channel mutant W434F.

Starkus JG, Kuschel L, Rayner MD, Heinemann SH. Starkus JG, et al. J Gen Physiol. 1998 Jul;112(1):85-93. doi: 10.1085/jgp.112.1.85. J Gen Physiol. 1998. PMID: 9649585 Free PMC article.

5

Voltage dependence of slow inactivation in Shaker potassium channels results from changes in relative K(+) and Na(+) permeabilities.

Starkus JG, Heinemann SH, Rayner MD. Starkus JG, et al. J Gen Physiol. 2000 Feb;115(2):107-22. doi: 10.1085/jgp.115.2.107. J Gen Physiol. 2000. PMID: 10653891 Free PMC article.

6

Unilateral exposure of Shaker B potassium channels to hyperosmolar solutions.

Starkus JG, Schlief T, Rayner MD, Heinemann SH. Starkus JG, et al. Biophys J. 1995 Sep;69(3):860-72. doi: 10.1016/S0006-3495(95)79960-X. Biophys J. 1995. PMID: 8519986 Free PMC article.

7

State-dependent blocking mechanism of Kv 1.3 channels by the antimycobacterial drug clofazimine.

Faouzi M, Starkus J, Penner R. Faouzi M, et al. Br J Pharmacol. 2015 Nov;172(21):5161-73. doi: 10.1111/bph.13283. Epub 2015 Oct 9. Br J Pharmacol. 2015. PMID: 26276903 Free PMC article.

8

Pharmacology of JNJ-28583113: A novel TRPM2 antagonist.

Fourgeaud L, Dvorak C, Faouzi M, Starkus J, Sahdeo S, Wang Q, Lord B, Coate H, Taylor N, He Y, Qin N, Wickenden A, Carruthers N, Lovenberg TW, Penner R, Bhattacharya A. Fourgeaud L, et al. Eur J Pharmacol. 2019 Jun 15;853:299-307. doi: 10.1016/j.ejphar.2019.03.043. Epub 2019 Apr 6. Eur J Pharmacol. 2019. PMID: 30965058

9

Point mutations in IIS4 alter activation and inactivation of rat brain IIA Na channels in Xenopus oocyte macropatches.

Fleig A, Fitch JM, Goldin AL, Rayner MD, Starkus JG, Ruben PC. Fleig A, et al. Among authors: starkus jg. Pflugers Arch. 1994 Jul;427(5-6):406-13. doi: 10.1007/BF00374254. Pflugers Arch. 1994. PMID: 7971139

10

pH-dependent modulation of Kv1.3 inactivation: role of His399.

Somodi S, Varga Z, Hajdu P, Starkus JG, Levy DI, Gáspár R, Panyi G. Somodi S, et al. Among authors: starkus jg. Am J Physiol Cell Physiol. 2004 Oct;287(4):C1067-76. doi: 10.1152/ajpcell.00438.2003. Epub 2004 Jun 16. Am J Physiol Cell Physiol. 2004. PMID: 15201143 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

33 results

Search Page

Filters